Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers

Overview of attention for article published in Journal of Translational Medicine, October 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 5 news stories from 5 outlets.

Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of stem cell-based delivery of oncolytic…

- Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of stem cell-based delivery of…

LA JOLLA, Calif.--(BUSINESS WIRE)--Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of…

LA JOLLA, Calif., October 25, 2021 BUSINESS WIRE Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 1 additional news stories.